Relmada Therapeutics Inc
(STU:4E2)
€
3.88
-0.040 (-1.02%)
Market Cap: 418.23 Mil
Enterprise Value: 231.84 Mil
PE Ratio: 0
PB Ratio: 2.37
GF Score: 29/100 Relmada Therapeutics Inc (STU:4E2) Transcripts
- 1